The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Ebola virus: from discovery to vaccine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS
Buhl, R., Holroyd, K., Mastrangeli, A., Cantin, A., Jaffe, H. A., Wells, F., Saltini, C., & Crystal, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91909-0 · Cited by 723
Catastrophic ape decline in western equatorial Africa
Walsh, P. D., Abernethy, K. A., Bermejo, M., Beyers, R., De Wachter, P., Akou, M. E., Huijbregts, B., Mambounga, D. I., Toham, A. K., Kilbourn, A. M., et al. (2003) · Nature · doi:10.1038/nature01566 · Cited by 681
Hemorrhagic Fever Viruses as Biological Weapons: Medical and Public Health Management
Borio, L., Inglesby, T., Peters, C. J., Schmaljohn, A. L., Hughes, J. M., Jahrling, P. B., Ksiazek, T., Johnson, K. M., Meyerhoff, A., O'Toole, T., et al. (2002) · JAMA · doi:10.1001/jama.287.18.2391 · Cited by 672
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans
Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L., & Delgado, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6841-6844.2002 · Cited by 652
Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C. J., & Nichol, S. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3602 · Cited by 552
Baize, S., Leroy, E. M., Georges-Courbot, M.-C., Capron, M., Lansoud-Soukate, J., Debré, P., Fisher-Hoch, S. P., McCormick, J. B., & Georges, A. J. (1999) · Nature Medicine · doi:10.1038/7422 · Cited by 551
Processing of the Ebola virus glycoprotein by the proprotein convertase furin
Volchkov, V. E., Feldmann, H., Volchkova, V. A., & Klenk, H.-D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5762 · Cited by 497
Self-citationA Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492
Mühlberger, E., Weik, M., Volchkov, V. E., Klenk, H.-D., & Becker, S. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2333-2342.1999 · Cited by 486
Self-citationThe Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478
Self-citationEpitopes Involved in Antibody-Mediated Protection from Ebola Virus
Wilson, J. A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A. L., & Hart, M. K. (2000) · Science · doi:10.1126/science.287.5458.1664 · Cited by 459
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
Mupapa, K., Massamba, M., Kibadi, K., Kuvula, K., Bwaka, A., Kipasa, M., Colebunders, R., Muyembe‐Tamfum, J. J., & the International Scientific and Technical Committee (1999) · The Journal of Infectious Diseases · doi:10.1086/514298 · Cited by 420
Nabel, G. J., Yang, Z., Duckers, H. J., Sullivan, N. J., Sanchez, A., & Nabel, E. G. (2000) · Nature Medicine · doi:10.1038/78645 · Cited by 413
Human asymptomatic Ebola infection and strong inflammatory response
Leroy, E., Baize, S., Volchkov, V., Fisher-Hoch, S., Georges-Courbot, M.-C., Lansoud-Soukate, J., Capron, M., Debré, P., Georges, A., & McCormick, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02405-3 · Cited by 411
Preliminary report: isolation of Ebola virus from monkeys imported to USA
Jahrling, P. B., Geisbert, T. W., Johnson, E. D., Peters, C. J., Dalgard, D. W., & Hall, W. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)90737-p · Cited by 403
Isolation and partial characterisation of a new strain of Ebola virus
Le Guenno, B., Formenty, P., Wyers, M., Gounon, P., Walker, F., & Boesch, C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90925-7 · Cited by 402
Inflammatory responses in Ebola virus-infected patients
BAIZE, S., LEROY, E. M., GEORGES, A. J., GEORGES-COURBOT, M.-C., CAPRON, M., BEDJABAGA, I., LANSOUD-SOUKATE, J., & MAVOUNGOU, E. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01800.x · Cited by 370
Ksiazek, T. G., Rollin, P. E., Williams, A. J., Bressler, D. S., Martin, M. L., Swanepoel, R., Burt, F. J., Leman, P. A., Khan, A. S., Rowe, A. K., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514321 · Cited by 359
Wool-Lewis, R. J., & Bates, P. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.3155-3160.1998 · Cited by 357
Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Mahanty, S., Hutchinson, K., Agarwal, S., Mcrae, M., Rollin, P. E., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2797 · Cited by 354
Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP
Noda, T., Sagara, H., Suzuki, E., Takada, A., Kida, H., & Kawaoka, Y. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.4855-4865.2002 · Cited by 349
Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs
Connolly, B. M., Steele, K. E., Davis, K. J., Geisbert, T. W., Kell, W. M., Jaax, N. K., & Jahrling, P. B. (1999) · The Journal of Infectious Diseases · doi:10.1086/514305 · Cited by 308
Villinger, F., Rollin, P. E., Brar, S. S., Chikkala, N. F., Winter, J., Sundstrom, J. B., Zaki, S. R., Swanepoel, R., Ansari, A. A., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514283 · Cited by 307
Volchkov, V. E., Volchkova, V. A., Mühlberger, E., Kolesnikova, L. V., Weik, M., Dolnik, O., & Klenk, H.-D. (2001) · Science · doi:10.1126/science.1057269 · Cited by 303
Self-citationApoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
Geisbert, T. W., Hensley, L. E., Gibb, T. R., Steele, K. E., Jaax, N. K., & Jahrling, P. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780021 · Cited by 302
Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman Primates
Hevey, M., Negley, D., Pushko, P., Smith, J., & Schmaljohn, A. (1998) · Virology · doi:10.1006/viro.1998.9367 · Cited by 262
Distinct Cellular Interactions of Secreted and Transmembrane Ebola Virus Glycoproteins
Yang, Z.-Y., Delgado, R., Xu, L., Todd, R. F., Nabel, E. G., Sanchez, A., & Nabel, G. J. (1998) · Science · doi:10.1126/science.279.5353.1034 · Cited by 261
An Introduction to Ebola: The Virus and the Disease
Peters, C. J., & LeDuc, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/514322 · Cited by 260
Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages
Feldmann, H., Bugany, H., Mahner, F., Klenk, H. D., Drenckhahn, D., & Schnittler, H. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2208-2214.1996 · Cited by 256
Self-citationEvaluation in Nonhuman Primates of Vaccines against Ebola Virus
Geisbert, T. W., Pushko, P., Anderson, K., Smith, J., Davis, K. J., & Jahrling, P. B. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0805.010284 · Cited by 248
The role of the Type I interferon response in the resistance of mice to filovirus infection
Bray, M. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-6-1365 · Cited by 228
Mühlberger, E., Lötfering, B., Klenk, H.-D., & Becker, S. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8756-8764.1998 · Cited by 228
Self-citation[The epidemic of Ebola haemorrhagic fever in Sudan and Zaire, 1976: introductory note].
Brès, P. (1978) · Europe PMC (PubMed Central) · Cited by 225
Neumann, G., Feldmann, H., Watanabe, S., Lukashevich, I., & Kawaoka, Y. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.406-410.2002 · Cited by 211
Self-citationFeldmann, H., & Klenk, H.-D. (1996) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60733-2 · Cited by 209
Self-citationFolate Receptor-α Is a Cofactor for Cellular Entry by Marburg and Ebola Viruses
Chan, S. Y., Empig, C. J., Welte, F. J., Speck, R. F., Schmaljohn, A. L., Kreisberg, J. F., & Goldsmith, M. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00418-4 · Cited by 208
Zur Ätiologie einer unbekannten, von Affen ausgegangenen menschlichen Infektionskrankheit
Siegert, R., Shu, H.-L., Slenczka, W., Peters, D., & Müller, G. (1967) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1106144 · Cited by 207
Antibody-Dependent Enhancement of Ebola Virus Infection
Takada, A., Feldmann, H., Ksiazek, T. G., & Kawaoka, Y. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7539-7544.2003 · Cited by 206
Self-citationParren, P. W. H. I., Geisbert, T. W., Maruyama, T., Jahrling, P. B., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6408-6412.2002 · Cited by 204
Pushko, P., Bray, M., Ludwig, G. V., Parker, M., Schmaljohn, A., Sanchez, A., Jahrling, P. B., & Smith, J. F. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00113-4 · Cited by 198
Immunization for Ebola virus infection
Xu, L., Sanchez, A., Yang, Z.-Y., Zaki, S. R., Nabel, E. G., Nichol, S. T., & Nabel, G. J. (1998) · Nature Medicine · doi:10.1038/nm0198-037 · Cited by 196
Viral hemorrhagic fever – a vascular disease?
Feldmann, H., & Schnittler, H. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613397 · Cited by 193
Self-citationMartini, G. A., & Siegert, R. (1971) · Cited by 176
Jahrling, P. B., Geisbert, J., Swearengen, J. R., Jaax, G. P., Lewis, T., Huggins, J. W., Schmidt, J. J., LeDuc, J. W., & Peters, C. J. (1996) · Imported Virus Infections · doi:10.1007/978-3-7091-7482-1_12 · Cited by 175
DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal Challenge
Vanderzanden, L., Bray, M., Fuller, D., Roberts, T., Custer, D., Spik, K., Jahrling, P., Huggins, J., Schmaljohn, A., & Schmaljohn, C. (1998) · Virology · doi:10.1006/viro.1998.9176 · Cited by 172
The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus
Becker, S., Spiess, M., & Klenk, H.-D. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-2-393 · Cited by 171
Self-citationPathologic Features of Filovirus Infections in Humans
Zaki, S. R., & Goldsmith, C. S. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59949-1_7 · Cited by 166
Bray, M., Hatfill, S. J., Hensley, L. E., & Huggins, J. W. (2001) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0503 · Cited by 156
Ebola Virus Haemorrhagic Fever
Halstead, S. B. (1979) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1979.28.775 · Cited by 155
Gupta, M., Mahanty, S., Bray, M., Ahmed, R., & Rollin, P. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4649-4654.2001 · Cited by 147
Molecular Characterization of Guinea Pig-Adapted Variants of Ebola Virus
Volchkov, V. E., Chepurnov, A. A., Volchkova, V. A., Ternovoi, V. A., & Klenk, H. (2000) · Virology · doi:10.1006/viro.2000.0572 · Cited by 146
Self-citationPathogenesis of Experimental Ebola Zaire Virus Infection in BALB/c Mice
Gibb, T. R., Bray, M., Geisbert, T. W., Steele, K. E., Kell, W. M., Davis, K. J., & Jaax, N. K. (2001) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0502 · Cited by 144
Ebola virus haemorrhagic fever
Pattyn, S. R. (1978) · Cited by 141
Davis, K. J., Anderson, A. O., Geisbert, T. W., Steele, K. E., Geisbert, J. B., Vogel, P., Connolly, B., Huggins, J. W., Jahrling, P. B., & Jaax, N. K. (1997) · PubMed · Cited by 123
Volchkov, V. E., Blinov, V. M., & Sv, N. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80662-z · Cited by 122
Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein
Takada, A., Watanabe, S., Okazaki, K., Kida, H., & Kawaoka, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2324-2330.2001 · Cited by 116
Takada, A., Feldmann, H., Ströeher, U., Bray, M., Watanabe, S., Ito, H., McGregor, M. W., & Kawaoka, Y. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1069-1074.2003 · Cited by 114
Self-citationHarcourt, B. H., Sanchez, A., & Offermann, M. K. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3491-3496.1999 · Cited by 113
Release of Viral Glycoproteins during Ebola Virus Infection
Volchkov, V. E., Volchkova, V. A., Slenczka, W., Klenk, H., & Feldmann, H. (1998) · Virology · doi:10.1006/viro.1998.9143 · Cited by 112
Self-citationBiosynthesis and role of filoviral glycoproteins
Feldmann, H., Volchkov, V. E., Volchkova, V. A., Ströher, U., & Klenk, H. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-12-2839 · Cited by 111
Self-citationVaccine Potential of Ebola Virus VP24, VP30, VP35, and VP40 Proteins
Wilson, J. A., Bray, M., Bakken, R. R., & Hart, M. K. (2001) · Virology · doi:10.1006/viro.2001.1012 · Cited by 109
Cadherin-5 redistribution at sites of TNF-α and IFN-γ-induced permeability in mesenteric venules
Wong, R. K., Baldwin, A. L., & Heimark, R. L. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.2.h736 · Cited by 105
(1971) · Springer eBooks · doi:10.1007/978-3-662-01593-3 · Cited by 104
Hemorrhagic fever virus-induced changes in hemostasis and vascular biology
Chen, J. P., & Cosgriff, T. M. (2000) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200007000-00010 · Cited by 102
Recombinant Human Monoclonal Antibodies to Ebola Virus
Maruyama, T., Parren, P. W. H. I., Sanchez, A., Rensink, I., Rodríguez, L. L., Khan, A. S., Peters, C. J., & Burton, D. R. (1999) · The Journal of Infectious Diseases · doi:10.1086/514280 · Cited by 102
INACTIVATED VACCINE FOR EBOLA VIRUS EFFICACIOUS IN GUINEAPIG MODEL
Lupton, H. W., Lambert, R. D., Bumgardner, D. L., et al. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92352-1 · Cited by 98
Classification, Structure, and Replication of Filoviruses
Feldmann, H., & Kiley, M. P. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_1 · Cited by 97
Self-citationMolecular Pathogenesis of Filovirus Infections: Role of Macrophages and Endothelial Cells
Schnittler, H., & Feldmann, H. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_10 · Cited by 96
Self-citationHerpes Zoster: Risk Categories for Persistent Pain
Whitley, R. J., Weiss, H. L., Soong, S.-J., & Gnann, J. W. (1999) · The Journal of Infectious Diseases · doi:10.1086/314562 · Cited by 87
Chan, S. Y., Ma, M. C., & Goldsmith, M. A. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-9-2155 · Cited by 79
Ebola Virus Secretory Glycoprotein (sGP) Diminishes FcγRIIIB-to-CR3 Proximity on Neutrophils
Kindzelskii, A. L., Yang, Z.-Y., Nabel, G. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.953 · Cited by 74
Vaccine research efforts for filoviruses
Hart, M. K. (2003) · International Journal for Parasitology · doi:10.1016/s0020-7519(03)00064-x · Cited by 62
Animal Pathology of Filoviral Infections
Ryabchikova, E. I., Kolesnikova, L. V., & Sv, N. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_9 · Cited by 55
Immune Response to Filovirus Infections
Ignatyev, G. M. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59949-1_11 · Cited by 34
Cited by
Salari, N., Hosseinian-Far, A., Jalali, R., Vaisi-Raygani, A., Rasoulpoor, S., Mohammadi, M., Rasoulpoor, S., & Khaledi-Paveh, B. (2020) · Globalization and Health · doi:10.1186/s12992-020-00589-w · Cited by 3,560
“There have been several viral diseases in the past 20 years including Severe Acute Respiratory Syndrome (SARS) in 2003, influenza virus with the H1N1 subtype in 2009, Middle East Respiratory Syndrome (MERS) in 2012, and Ebola virus in 2014 [3-5].”
BackgroundFeldmann, H., & Geisbert, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,374
Self-citationCrimean-Congo haemorrhagic fever
Ergönül, Ö. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70435-2 · Cited by 1,252
Kisely, S., Warren, N., McMahon, L., Dalais, C., Henry, I., & Siskind, D. (2020) · BMJ · doi:10.1136/bmj.m1642 · Cited by 1,056
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
Jones, S. M., Feldmann, H., Ströher, U., Geisbert, J. B., Fernando, L., Grolla, A., Klenk, H.-D., Sullivan, N. J., Volchkov, V. E., Fritz, E. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1258 · Cited by 687
Self-citation
Metadata
- Authors
- Feldmann, H., Jones, S., Klenk, H.-D., & Schnittler, H.-J.
- Venue
- Nature Reviews Immunology
- Published
- 2003-08
- Volume
- 3
- Issue
- 8
- Pages
- 677-685
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1510487586
- Cited by
- 308
- References
- 77
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.